Brittany Bankhead-Kendall, MD, a trauma surgeon and critical care doctor at Texas Tech University Health Sciences Center in Lubbock, tweeted “Post-COVID lungs look worse than any type of terrible smoker’s lung we’ve ever seen. And they clott off. And the shortness of breath lingers… & on… & on.”
Symptomatic patients almost always had a subsequent chest X-ray that showed severe lung scarring, while asymptomatic patients had a worrisome X-ray 70 percent to 80 percent of the time, Dr. Bankhead-Kendall told CBS based on anecdotal experience.
“There are still people who say ‘I’m fine. I don’t have any issues,’ and you pull up their chest X-ray and they absolutely have a bad chest X-ray,” she said. “You’ll see either a lot of that white, dense scarring or you’ll see it throughout the entire lung. Even when you’re not feeling problems now the fact that that’s on your chest X-ray — it sure is indicative of you possibly having problems later on.”
Dr. Bankhead-Kendall noted it’s still too early to tell whether the severe lung scarring seen in some patients will heal.
More articles on public health:
Daily COVID-19 deaths top 4,000 for 3rd day; WHO team arrives in China to investigate virus origin — 5 updates
California hospitals should prepare for crisis care, hospital association CEO says
States ranked by percentage of COVID-19 vaccines administered
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
